[Facioscapulohumeral muscular dystrophy]

Ryoikibetsu Shokogun Shirizu. 2001:(35):39-45.

[Article in Japanese]

Authors

M Nakagawa¹, I Higuchi

Affiliation

¹ Third Department of Internal Medicine, Kagoshima University Faculty of Medicine.

PMID: 11555966

No abstract available

Publication types

Review

MeSH terms

Adrenergic beta-Agonists / therapeutic use
Albuterol / therapeutic use
Chromosomes, Human, Pair 4 / genetics
Deoxyribonucleases, Type II Site-Specific / genetics
Diagnosis, Differential
Humans
Muscular Dystrophy, Facioscapulohumeral* / genetics
Muscular Dystrophy, Facioscapulohumeral* / physiopathology
Prognosis
Repetitive Sequences, Nucleic Acid / genetics
Sequence Deletion

Substances

Adrenergic beta-Agonists
Deoxyribonucleases, Type II Site-Specific
GGTACC-specific type II deoxyribonucleases
Albuterol